Immediate and Late Outcomes of Bronchial and Systemic Artery Embolization for Palliative Treatment of Patients With Nonsmall-Cell Lung Cancer Having Hemoptysis 7 w! f# ~# A# m1 C/ N9 J% e' B0 iBackground: Hemoptysis in patients with advanced lung cancer can be a life threatening.1 o- V @7 g. l" P4 _( i) T
Objectives: To evaluate immediate outcomes and late outcomes of bronchial artery embolization (BAE) for palliative treatment in patients with advanced nonsmall-cell lung cancer (NSCLC) having hemoptysis.' v& z% t6 j1 ]" w: M" _8 i
Methods: The BAE was performed in 28 patients with NSCLC. Hemoptysis was defined as follows: massive bleeding greater than 300 mL within 24 hours (n = 8), moderate bleeding of 100 to 300 mL within 24 hours (n =12), and slight bleeding less than100 mL within 24 hours (n = 8). ) S7 R! ^- \5 h3 t0 WResults: Success rate was 96%. Immediate clinical success within 24 hours after BAE was achieved in 22 of the 27 patients who underwent embolization. ) L* ?9 \- ]6 C# \ ]( XConclusions: The BAE with gelatin sponge particles can provide good management of hemoptysis as a palliative treatment in patients with advanced NSCLC.